Significant Phase 2 Findings from KAHR Bio on DSP107 for Colorectal Cancer Therapy KAHR Bio announced impressive Phase 2 results for DSP107, showing extended survival in colorectal cancer by combining it with atezolizumab therapy.

Significant Phase 2 Findings from KAHR Bio on DSP107 for Colorectal Cancer Therapy #Israel #Colorectal_Cancer #DSP107 #KAHR_Bio #Modi'in

KAHR Bio's DSP107 Shows Promising Phase 2 Results in Colorectal Cancer Treatment via Anti-PD-L1 Combination Therapy KAHR Bio's innovative Phase 2 trial reveals compelling results for DSP107 combined with anti-PD-L1 treatment in colorectal cancer, enhancing survival rates beautifully.

KAHR Bio's DSP107 Shows Promising Phase 2 Results in Colorectal Cancer Treatment via Anti-PD-L1 Combination Therapy #Israel #Colorectal_Cancer #DSP107 #KAHR_Bio #Modi'in